Sulzermedica's sales up 10% in first nine months:
This article was originally published in Clinica
Executive Summary
Sulzermedica, the medical arm of Swiss engineering company Sulzer, reported sales of SwFr 845 million ($680 million) in the first nine months, up 10%. Orders were up on the same period in the previous year. Group sales were SwFr 4,153 million, down 2%. The company says that net income for 1996 will be down on last year's figure. This is largely due to damages of $73 million that the company has to pay resulting from a patent infringement lawsuit with Stryker (see Clinica No 726, p 12).